Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies

Authors

• Dawn M. Davis, Departments of Dermatology and Pediatrics, Mayo Clinic, Rochester, Minnesota.
• Aaron M. Drucker, Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
• Ali Alikhan, Department of Dermatology, Sutter Medical Foundation, Sacramento, California.
• Lionel Bercovitch, Department of Dermatology, Warren Alpert Medical School of Brown University, Providence, Rhode Island.
• David E. Cohen, The Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York.
• Jennifer M. Darr, Department of Pediatrics, Pediatric Behavioral Health, National Jewish Health, Denver, Colorado.
• Lawrence F. Eichenfield, Departments of Dermatology and Pediatrics, University of California San Diego and Rady Children's Hospital San Diego, San Diego, California.
• Lindsy Frazer-Green, American Academy of Dermatology, Rosemont, Illinois. Electronic address: lfrazer-green@aad.org.
• Amy S. Paller, Departments of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
• Kathryn Schwarzenberger, Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
• Jonathan I. Silverberg, Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
• Anne Marie Singh, Departments of Pediatrics, Dermatology and Medical Microbiology/Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
• Peggy A. Wu, Department of Dermatology, University of California, Davis, Sacramento, California.
• Robert Sidbury, Division of Dermatology, Department of Pediatrics, University of Washington School of Medicine and Seattle Children's Hospital, Seattle, Washington.

Document Type

Journal Article

Publication Date

11-3-2023

Journal

Journal of the American Academy of Dermatology

DOI

10.1016/j.jaad.2023.08.103

Keywords

JAK inhibitor; atopic dermatitis; azathioprine; biologic; cyclosporine; dupilumab; eczema; methotrexate; phototherapy

Abstract

BACKGROUND: The summarized guidelines update the 2014 recommendations for the management of AD with phototherapy and systemic therapies. METHODS: A multidisciplinary workgroup conducted a systematic review and applied the GRADE approach for assessing the certainty of the evidence and formulating and grading recommendations. RESULTS: The workgroup developed 11 recommendations on the management of AD in adults with phototherapy and systemic therapies, including biologics, oral Janus Kinase inhibitors, and other immunomodulatory medications. CONCLUSIONS: The evidence supported strong recommendations for the use of dupilumab, tralokinumab, abrocitinib, baricitinib, and upadacitinib and conditional recommendations in favor of using phototherapy, azathioprine, cyclosporine, methotrexate, and mycophenolate, and against the use of systemic corticosteroids.

APA Citation

Davis, Dawn M.; Drucker, Aaron M.; Alikhan, Ali; Bercovitch, Lionel; Cohen, David E.; Darr, Jennifer M.; Eichenfield, Lawrence F.; Frazer-Green, Lindsy; Paller, Amy S.; Schwarzenberger, Kathryn; Silverberg, Jonathan I.; Singh, Anne Marie; Wu, Peggy A.; and Sidbury, Robert, "Executive summary: Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies" (2023). GW Authored Works. Paper 3842.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/3842

Department

Dermatology